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Abstract 
The spleen is the largest lymphatic organ that acts as a site for filtration of foreign particles from the blood, 
erythropoiesis and hematopoiesis. Splenectomy represents the first line of treatment for spontaneous splenic 
rupture, abscesses, cysts, tumours. It is also used to control hereditary, autoimmune, and myeloproliferative 
disorders alternatively. Numerous diseases have been indicated for surgery in non-traumatic spleen diseases 
such as non-traumatic spleen rupture, immune thrombocytopenic purpura (ITP), haemolytic anaemias, Felty's 
syndrome, Hodgkin's and non-Hodgkin's lymphoma among others. This result because the spleen is the most 
affected lymphoid organ following its overactivity that occurs during sequestration of dead or disrupted RBCs and 
lymphocytes. Abdominal pain is one of the major manifestations of splenomegaly, and can also designate other 
associated complications such as liver cirrhosis or bacterial endocarditis. As a secondary lymphoid organ, the 
spleen is more often an organ for lymphomas. Although splenectomy is a curative alternative in a few diseases, it 
is a complementary means of treating several other diseases. Splenectomy is a salvage therapy used when other 
therapeutic alternatives fail. Despite its indication in numerous diseases, controversies are still inbound of its use. 
 
 
 
 
 
Introduction 
 
As the largest of the lymphatic organs, the 
spleen also helps in the filtration of foreign matter from 
the blood and serves as a major site of erythropoiesis 
and hematopoiesis [1]. Weighing between 75 and 
250g in healthy adults, its size decreases with age [2], 
[3]. The spleen also acts as a storage site for iron, 
erythrocytes and platelets; and produces antibodies 
that remove bacteria [4], [5], [6]. Non-traumatic spleen 
rupture is a rare condition and can occur in a 
pathological spleen due to a variety of diseases [7]. 
 
Indications for Surgery in Non-traumatic 
Spleen Disease 
 
The most widespread indications for surgery 
in non-traumatic spleen disease includes conditions 
such as; immune thrombocytopenic purpura (ITP), 
haemolytic anaemias, malaria, thalassemia, splenic 
abscesses, congestive splenomegaly, splenic cysts, 
Felty's syndrome, Hodgkin's and non-Hodgkin's 
lymphoma, leukaemias, myelofibrosis e.t.c. [5], [6], [8]. 
Sreekar et al., and Schlittler and Dallagasperina, in 
their study, reports that splenic abscess is a rare and 
potentially fatal disease found especially in men, with 
Escherichia coli, Klebsiella pneumonia, 
Staphylococcus aureus and Salmonella typhi as 
causative factors [9], [10]. They also noted neoplasia, 
splenic infarcts, diabetes mellitus and 
immunosuppressive conditions as possible risk factors 
associated with the disease. Another condition that 
has drawn attention for surgery is a splenic cyst. 
Splenic cysts, which is asymptomatic with greater 
incidence in women are benign and without solid 
components [11]. The aetiologies of splenic cysts are 
numerous and include congenital, post-traumatic 
pseudocysts, peliosis and cystic neoplasias such as 
lymphangioma, hemangioma and lymphoma [11], 
[12]. 
Surgery has also been indicated in 
spontaneous splenic rupture (SSR) or non-traumatic 
rupture of the spleen, a rare, lethal, but potentially 
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treatable condition [13]. With predisposing factors 
such as leukaemias, malaria, lymphomas, liver 
cirrhosis, rheumatoid arthritis, pancreatitis, e.t.c, SSR 
accounts for more than 20 percent mortality rate [14], 
[15]. SSR diagnosis is important in subjects with 
haematological malignancies accompanied by 
unexpected abdominal pain, hypotension and shock 
[13]. The autosomal recessive disorders 
(Thalassemias) where one or more globin chains are 
reduced, results in defective erythropoiesis, 
haemolysis, and consequent hypersplenism following 
overactivity of the spleen. The disease courses with a 
hypercoagulable state, thrombosis with the risk of 
thromboembolic complications [16]. Haemangioma is 
the most common, asymptomatic benign neoplasm of 
the spleen that is also indicated for surgery [17]. 
Splenic metastases which are rare, have 0.9-1.86 
percent prevalence in breast cancer cases [18], [19].  
Malaria is an important disease especially in tropical 
regions of the world caused by protozoa of the genus 
Plasmodium spp. (falciparum, vivax, malariae, ovale 
and knowlesi). This disease affects the fundamental 
function of the spleen, as the spleen removes dead 
cells or cells infested by parasites and returning intact 
erythrocytes to the blood. It has also been observed 
that asplenic and hypoplastic individuals are more 
susceptible to fatal progress of the disease. This 
disease can cause spontaneous splenic rupture and 
in rare cases, splenic infarction, which are indications 
for splenectomy [20], [21]. Another close relative in 
terms of anaemia, is sickle cell disease (SCD), a 
genetic disease of haemoglobin leading to tissue 
damage and anaemia. 
One important complication of sickle cell 
disease is splenic sequestration, where red blood 
cells become entrapped in the spleen, causing the 
spleen to enlarge, pooling and resulting in the final 
destruction of red blood cells [22]. The spleen is also 
implicated in hereditary spherocytosis in that it is the 
site of sequestration and phagocytosis of non-
deformable red cell, leading to anaemia [23]. This 
disease is characterised by pallor resulting from the 
anaemia, jaundice from the hyperbilirubinemia and 
splenomegaly. While autoimmune haemolytic 
anaemia is a disorder caused by autoantibodies 
directed against red blood cells, idiopathic 
thrombocytopenic purpura (ITP) with no specific 
cause is characterised by thrombocytopenia and 
microangiopathic haemolytic anaemia, diagnosed by 
the definite presence of schizocytes in the peripheral 
blood smear film. Majority of these conditions may 
cause spleen enlargement. Spleen enlargement 
(splenomegaly) can also be caused by cirrhosis of the 
liver, lymphoma, and acquired immunodeficiency 
syndrome (AIDS) and venous thrombosis. 
Splenomegaly is characterised by pain in the upper 
left quadrant referred to the shoulder and sensation of 
early satiety [24]. Surgery is indicated in cases of 
severe thrombocytopenia associated with 
spontaneous bleeding, post-transplant splenic 
sequestration, or abdominal pain due to repeated 
splenic infarction [25]. Chronic venous congestion of 
the spleen, most often caused by sinusoidal intra-
hepatic cirrhosis or splenic artery aneurysm, which 
can produce chronic venous obstruction by direct 
compression of the splenic vein can also cause 
congestive splenomegaly (CS) [5], [26]. Splenectomy 
is indicated as the treatment of choice for patients with 
severe residual thrombocytopenia, with venous 
thrombosis as the underlying cause of CS. However, 
in splenic artery aneurysm, a satisfactory result has 
been obtained with a patient treated with aneurysm 
resection and/or complementary splenectomy [5], [26]. 
As a secondary lymphoid organ, the spleen is 
generally involved by lymphomas [27], [28]. While the 
primary splenic lymphomas (PSL) originate inside the 
organ, the splenic tissue is compromised by diffuse 
dissemination of Hodgkin's Lymphoma and Non-
Hodgkin's Lymphoma in the secondary splenic 
lymphomas (Silva and Gunasekera, 2015). Among the 
diverse haematological malignancies, lymphoid and 
myeloid leukaemias are well-known. Persons with 
these diseases may develop considerable 
splenomegaly and then splenic sequestration, which 
is responsible for the worsening of anaemia and pre-
existing thrombocytopenia in bone marrow failure, 
observed especially in leukaemias [29], [30]. Felty’s 
syndrome (FS) is a severe form of rheumatoid arthritis 
(RA) with longstanding, severe and erosive 
arthropathy. FS causes splenomegaly and 
neutropenia, which result from increased neutrophil 
sequestration, peripheral neutrophil destruction, and 
bone marrow failure to produce neutrophils. 
Splenomegaly which is manifested by abdominal pain 
from splenic infarcts, can indicate other complications 
such as liver cirrhosis or other infections, like bacterial 
endocarditis [9]. Surgery is indicated in the majority of 
these non-traumatic diseases affecting the spleen. 
This is because; the spleen is an important lymphoid 
organ, whose role in erythropoiesis, immunity cannot 
be denied, as it is often enlarged (splenomegaly) 
following excessive activity from sequestration of old 
and damaged RBCs and lymphocytes. This 
overactivity affects the blood supply to the spleen, 
increasing its risk of infection.  
 
 
Complications/Laparoscopy 
 
The major complications of surgery which 
may involve removing the spleen (splenectomy) 
include haemorrhage, thromboembolism, subphrenic 
abscess, thoracic infection and fulminate sepsis. The 
greater mortality rates are majorly due to 
haemorrhage, bacterial infections and myelofibrosis 
[4]. The risk of devastating post-splenectomy infection 
(OPSI) is both more common and is characterised by 
hypotension, altered consciousness or cardio-
circulatory shock. 
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Conclusion 
 
Splenectomy, despite being indicated in 
several conditions, is still controversial and remains 
open to further studies. Although splenectomy is a 
curative alternative in a small number of diseases, it is 
a complementary treatment in numerous other clinical 
disorders. While its purpose and its effects on the 
host’s homeostasis are not fully understood. Unlike its 
indication in trauma, it is compromised by chronic 
disease and with the use of corticosteroids; immunity 
is reduced in these patients. Clotting disorders, 
changes in platelet function and associated diseases 
are common. This exposes these individuals to 
serious risks and complications, greater morbidity and 
mortality rates compared to other intra-abdominal 
surgical procedures. Therefore, as a serious surgical 
procedure, splenectomy should be undertaken only 
after the depletion of the clinic and non-invasive 
therapeutics. 
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